Table 3.
Prevalence of symptoms suggestive of OAB and OAB-wet by geographical location and age
| Age range, years | Algeria | Egypt | Jordan | Lebanon | Total |
|---|---|---|---|---|---|
| OABa, n (%)b | |||||
| 40–55 | 228 (49.9) | 175 (61.2) | 182 (60.9) | 157 (48.9) | 742 (54.4) |
| 56–64 | 43 (53.1) | 102 (56.0) | 84 (54.9) | 71 (47.7) | 300 (53.1) |
| 65–74 | 11 (39.3) | 59 (52.7) | 51 (56.7) | 38 (52.8) | 159 (52.6) |
| ≥ 75 | 4 (57.1) | 9 (45.0) | 11 (57.9) | 10 (47.6) | 34 (50.7) |
| OAB-wetc, n (%)d | |||||
| 40–55 | 206 (90.4) | 160 (91.4) | 165 (90.7) | 145 (92.4) | 676 (91.1) |
| 56–64 | 37 (86.0) | 96 (94.1) | 73 (86.9) | 69 (97.2) | 275 (91.7) |
| 65–74 | 8 (72.7) | 54 (91.5) | 49 (96.1) | 34 (89.5) | 145 (91.2) |
| ≥ 75 | 4 (100) | 8 (88.9) | 11 (100) | 9 (90.0) | 32 (94.1) |
OAB overactive bladder
aOAB: Scoring overall ≥ 8 plus scores ≥ 1 on all urgency questions 2, 3 and 7 on the OAB-V8 questionnaire
bPercent (%) was calculated with a denominator of the number of patients in each age group (see Table 1)
cOAB-wet: Women with OAB1 plus scores ≥ 1 on questions 4 and 8 on the OAB-V8 questionnaire
dPercent (%) was calculated with a denominator of the number of women with symptoms suggestive of OAB in each age group